News|Articles|August 21, 2026

FDA-cleared vaginal device launches, asthma control as fetal protection, IVF's bladder symptom cues

Fact checked by: Contemporary OB/GYN Staff

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Thank you for visiting the Contemporary OB/GYN website. Take a look at some of our top stories from the past week (Monday, August 17, to Friday, August 21, 2026) and click on each link to read and watch anything you may have missed.

Asthma control as fetal protection in pregnancy, with Rachel Meislin, MD

Uncontrolled asthma, rather than the diagnosis itself or the medications used to treat it, is the primary driver of adverse pregnancy outcomes, according to Rachel Meislin, MD, board-certified OB-GYN and maternal-fetal medicine specialist at the Icahn School of Medicine at Mount Sinai, who discussed a review she co-authored in the American Journal of Obstetrics and Gynecology.
Click here to watch.

Labial agglutination in prepubescent girls: A review of etiology, diagnosis, and management

This review examines partial or complete fusion of the labia minora in prepubescent girls, finding the condition is usually benign and self-limited, most commonly linked to hypoestrogenism and local irritation, and best addressed with a standardized, conservative, education-focused approach to reduce unnecessary interventions.
Click here for the full article.

FDA-cleared, post-intercourse vaginal health device launches

LiviWell Inc. has officially launched its FDA-cleared device, Livi, designed to absorb semen and other vaginal discharge after intercourse, with the single-use polyurethane foam device inserted via a tampon-style applicator and cleared for use up to 15 minutes post-intercourse.
View the details here.

Bladder symptoms during IVF carry systemic cues that extend beyond the urinary tract

Bladder symptoms during in vitro fertilization are often dismissed as an expected adverse event, but they frequently carry diagnostic information extending well beyond the urinary tract, and integrating bladder health screening into routine fertility consultations rather than waiting for symptoms to emerge would meaningfully improve patient care, according to Aleece Fosnight, MSPAS, PA-C, founder of the Fosnight Center for Sexual Health.
Click here to watch.